Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres
托利那泮(ASTX660)联合标准根治性放化疗治疗宫颈癌的剂量递增:英国二级医疗中心开展的 1b 期 TiTE-CRM 临床试验(CRAIN)的研究方案
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12310-w
Hoskin, Peter; Lee, Marina; Dunkley, Denise; Danh, Mary; Wickens, Robin; Saunders, Geoff; Northey, Josh; Crabb, Simon; McFarlane, Vicky; Sadozye, Azmat; Cooper, Rachel; Mathew, Tony; Haslett, Kate; Reeves, Kim; Reed, Rachel; Bigos, Kamilla; Williams, Kaye J; Rowling, Emily; Choudhury, Ananya; Dancer, Sonia; Smith, Deb; Griffiths, Gareth